Biotech Stock Mailbag Readers' Portfolio: Update
The BSMRP, a portfolio of biotech and drug stocks chosen by readers of my weekly Mailbag, is down 23% this year.
Biotech Stocks: Lilly, Mannkind, Cumberland in spotlight
Eli Lilly & Co. shares fall on news it is ceasing development of a late-stage drug candidate for the treatment of Alzheimer's disease.
Biotech Distributor BDI Pharma Unveils Online Ordering Portal
COLUMBIA, SC--(Marketwire - August 16, 2010) - BDI Pharma, Inc. (BDI), the nation's fastest growing national distributor of biotech therapies, announced the successful launch of its proprietary on-line ordering system. The system, initially rolled out earlier this month, provides BDI's customers with the ability to place specialty pharmaceutical purchases on-line via the internet through a ...
The biotech stocks attracted diametrically opposed option volume on Friday
Biotech stocks were in focus on Friday, with options players placing new bets on InterMune, Inc...( Read More )
Deutsche Bank Picks Winners In Volatile Biotech Sector
The highly tradable biotech sector is often volatile as individual components fluctuate in relation to progress towards marketing approval, buyout speculation, or other catalysts.
Biotech Science News Unveils the Top 10 List of Life Science Organizations Worldwide
NEW YORK, NY--(Marketwire - 08/16/10) - Biotech Science News (BSN) today unveiled the Top 10 list of global life science organizations. Researchers from the organizations on the Top 10 list are a major force at life science meetings and their investigations help determine the research path for the life science community. The Top 10 list: University of California/UCSF Harvard University Mayo ...
Biotech Stocks: Amgen, Celgene, Biogen fall on analyst ratings
Analysts at Deutsche Bank initiate coverage of Amgen with a hold rating, citing valuation and weakened sales.
China Kangtai Cactus Biotech Q2 Revenue Up 34% to $8.7M Net Income up 989% to $3M First Half Year Revenue Up 45% to ...
HARBIN, China----China Kangtai Cactus Biotech Inc. , a vertically integrated grower, developer, manufacturer and marketer of a variety of cactus-based products in China, announced today that revenue for the second quarter ended June 30, 2010 increased 34% to $8.7 million from $6.5 million in the second quarter of 2009.
Sinovac Biotech second-quarter 2010 sales increase 131% to $10.3 million
Sinovac Biotech Ltd., a leading China-based vaccine manufacturer, announced today its unaudited financial results for the three-month and six-month periods ended June 30, 2010.
Biotech bypass: Why not here?
When world-class biotech labs come to Florida looking for a home, the Panhandle gets short shrift.